Compare Amylx Pharmaceuticals Inc (AMLX) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Matson Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Matson Inc trades at $204.7 (market cap $6.11B). The key difference: Matson Inc is far larger — about 2.3× Amylx Pharmaceuticals Inc's market cap, and Matson Inc pays a 0.74% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | MATX | |
|---|---|---|
Market Cap | $2.64B | $6.11B |
Sector | Health | Technology |
52-Week High | $24.19 | $223.55 |
52-Week Low | $7.82 | $88.05 |
Enterprise Value | $2.39B | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
